Should preclinical vascular abnormalities be measured in asymptomatic adults to improve cardiovascular risk stratification?

Current Opinion in Lipidology

Volumn 22, Issue 6, 2011, Pages 454-459

  De Graaf, Jacqueline ^a   Holewijn, Suzanne ^a   Stalenhoef, Anton F ^a   Sniderman, Allan D ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

arterial structure and function; atherosclerosis (subclinical); noninvasive imaging

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

ANKLE BRACHIAL INDEX; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG INDICATION; ECHOGRAPHY; HUMAN; PRIORITY JOURNAL; PULSE WAVE; REFERENCE VALUE; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; SCREENING; STANDARDIZATION;

ANKLE BRACHIAL INDEX; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CAROTID STENOSIS; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PULSE; REFERENCE VALUES; RISK FACTORS;

EID: 81855194377     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32834c6245     Document Type: Review

References (40)

1. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 151:474-482.
2. Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010; 56:e50-e103.
3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
4. Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32:1769-1818.
5. Sniderman AD, Williams K, Contois JH, et al. A meta-analysis of low-density lipoprotein cholesterol, nonhigh-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes 2011; 4:337-345.
6. Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006; 113:791-798.
7. Spence JD. Technology insight: ultrasound measurement of carotid plaque-patient management, genetic research, and therapy evaluation. Nat Clin Pract Neurol 2006; 2:611-619. (Pubitemid 44614087)
8. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and metaanalysis. Circulation 2007; 115:459-467. (Pubitemid 46184197)
9. Nambi V, Chambless L, He M, et al. Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study. Eur Heart J 2011; [Epub ahead of print]. doi: 10.1093/eurheartj/
10. Folsom AR, Kronmal RA, Detrano RC, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008; 168:1333-1339. (Pubitemid 351930841)
11. Lorenz MW, von Kegler S, Steinmetz H, et al. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37:87-92. (Pubitemid 43732053)
12. Polak JF, Pencina MJ, Pencina KM, et al. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011; 365:213-221.
13. Aguilar-Shea AL, Gallardo-Mayo C, Garrido-Elustondo S, et al. Carotid intima-media thickness as a screening tool in cardiovascular primary prevention. Eur J Clin Invest 2011; 41:521-526.
14. Nambi V, Chambless L, Folsom AR, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010; 55:1600-1607.
15. Rosvall M, Janzon L, Berglund G, et al. Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med 2005; 257:430-437. (Pubitemid 40604547)
16. Sinning C, Wild PS, Echevarria FM, et al. Sex differences in early carotid atherosclerosis (from the community-based Gutenberg-Heart Study). Am J Cardiol 2011; 107:1841-1847.
17. Finn AV, Kolodgie FD, Virmani R. Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol 2010; 30:177-181.
18. Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: A meta-analysis. Atherosclerosis 2011.
19. Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 2010; 30:182-185.
20. Xie W, Liang L, Zhao L, et al. Combination of carotid intima-media thickness and plaque for better predicting risk of ischaemic cardiovascular events. Heart 2011; 97:1326-1331.
21. Holewijn S, den Heijer M, Swinkels DW, et al. The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis. J Clin Endocrinol Metab 2009; 94:2893-2899.
22. Holewijn S, den Heijer M, Swinkels DW, et al. Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk. J Intern Med 2010; 268:567-577.
23. Al-Shali K, House AA, Hanley AJ, et al. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions. Atherosclerosis 2005; 178:319-325. (Pubitemid 40193446)
24. Bhuiyan AR, Srinivasan SR, Chen W, et al. Correlates of vascular structure and function measures in asymptomatic young adults: the Bogalusa Heart Study. Atherosclerosis 2006; 189:1-7. (Pubitemid 44441293)
25. Morrison KM, Dyal L, Conner W, et al. Cardiovascular risk factors and noninvasive assessment of subclinical atherosclerosis in youth. Atherosclerosis 2010; 208:501-505.
26. Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003; 34:1203-1206. (Pubitemid 36547514)
27. Muiesan ML, Salvetti M, Paini A, et al. Pulse wave velocity and cardiovascular risk stratification in a general population: the Vobarno study. J Hypertens 2010; 28:1935-1943.
28. Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113:664-670.
29. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28:1462-1536.
30. The Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010; 31:2338-2350.
31. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113:657-663.
32. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39:10-15. (Pubitemid 34098081)
33. Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010; 121:505-511.
34. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318-1327.
35. Sehestedt T, Olsen MH. Subclinical organ damage and cardiovascular risk prediction. Blood Press 2010; 19:132-139.
36. McDermott MM, Liu K, Criqui MH, et al. Ankle-brachial index and subclinical cardiac and carotid disease: the multiethnic study of atherosclerosis. Am J Epidemiol 2005; 162:33-41. (Pubitemid 40884998)
37. Lee AJ, Price JF, Russell MJ, et al. Improved prediction of fatal myocardial infarction using the ankle brachial index in addition to conventional risk factors: the Edinburgh Artery Study. Circulation 2004; 110:3075-3080. (Pubitemid 39492001)
38. Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300:197-208. (Pubitemid 351969304)
39. Holewijn S, den Heijer M, van Tits LJ, et al. Impact of waist circumference versus adiponectin level on subclinical atherosclerosis: a cross-sectional analysis in a sample from the general population. J Intern Med 2010; 267:588-598.
40. de Liefde I, Klein J, Bax JJ, et al. Exercise ankle brachial index adds important prognostic information on long-term out-come only in patients with a normal resting ankle brachial index. Atherosclerosis 2011; 216:365-369.